# A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer

> **NCT00717938** · PHASE3 · COMPLETED · sponsor: **Lund University Hospital** · enrollment: 390 (actual)

## Conditions studied

- Small Cell Lung Cancer

## Interventions

- **DRUG:** cisplatinum or carboplatin and e.g.etoposide.
- **DRUG:** cisplatinum or carboplatin and e.g.etoposide+enoxaparin

## Key facts

- **NCT ID:** NCT00717938
- **Lead sponsor:** Lund University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 390 (ACTUAL)
- **Last updated:** 2017-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00717938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00717938, "A Study of Standard Treatment +/- Enoxaparin in Small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00717938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*